Travoprost Ophthalmic Solution
These highlights do not include all the information needed to use TRAVOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TRAVOPROST OPHTHALMIC SOLUTION.TRAVOPROST ophthalmic solution, for topical ophthalmic useInitial U.S. Approval: 2001
Approved
Approval ID
c17aa704-1ec6-4610-a448-4964bdb1cba1
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 29, 2020
Manufacturers
FDA
Sandoz Inc
DUNS: 005387188
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
travoprost
PRODUCT DETAILS
NDC Product Code0781-6185
Application NumberNDA021994
Marketing CategoryC73605
Route of AdministrationOPHTHALMIC
Effective DateSeptember 29, 2017
Generic Nametravoprost
INGREDIENTS (9)
TRAVOPROSTActive
Quantity: 0.04 mg in 1 mL
Code: WJ68R08KX9
Classification: ACTIB
PEG-40 CASTOR OILInactive
Code: 4ERD2076EF
Classification: IACT
BORIC ACIDInactive
Code: R57ZHV85D4
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
ZINC CHLORIDEInactive
Code: 86Q357L16B
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT